[#item_full_content]
Merck snags Chinese obesity drug in nearly US$2 billion deal
2024-12-19T00:01:07-05:00December 19th, 2024|
Related Posts
-
South Korea potential growth rate estimated around 2%, central bank says
December 19th, 2024 -
BOJ keeps rates steady by 8-1 vote, board member Tamura dissents
December 19th, 2024 -
PBOC offers strongest yuan support since July after US dollar gains
December 19th, 2024 -
Japan brokerages boost pay, perks for retirement-age staff
December 19th, 2024